Sierra Oncology Inc (SRRA)

US82640U4040 - Common Stock

54.99  +0.02 (+0.04%)

After market: 54.99 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-3-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
N/A0.00300.00K0.000.00
Operating Expenses
102.64M94.58M65.24M66.99M55.42M
Research and Development
70.75M67.15M45.12M53.25M41.08M
Selling, General, and Administrative Expenses
31.90M27.43M20.12M13.74M14.34M
Operating Income
-102.64M-94.58M-64.94M-66.99M-55.42M
Interest Income/Expense
N/A0.00-16.24M-20.93MN/A
Other Income/Expense
-7.00K-80.00K420.00K-520.00K1.78M
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-102.75M-94.66M-80.76M-88.44M-53.64M
Income Tax
-80.00K0.00140.00K-160.00K-300.00K
Net Income
-102.68M-94.66M-80.90M-88.28M-53.34M
EBITDA
-102.30M-94.28M-64.70M-66.91M-55.31M
 
Per Share Data
EPS Diluted Total Ops
-6.76-7.14-7.70-30.34-30.14
Non GAAP EPS
-6.77-7.15-5.91-29.48-30.00
 
Statistics
Profit Margin
N/AN/A-26966.67%N/AN/A
Operating Profit Margin
N/AN/A-21646.67%N/AN/A

All data in USD

Charts